CAR-T’s commercial challenge isn’t making bigger batches. It’s making thousands of patient-specific manufacturing runs behave like one reliable system. In vivo aims to eliminate the batch altogether.
Some of the world's top automotive designers explain why concept cars still matter, why so many never reach production, and why today's concepts often feel less exciting than those from decades past.
Biopharmas developing CAR T therapies for autoimmune indications face major barriers to maximizing the market. Advances in ...
The small black dots around a car’s windshield have an important purpose, helping protect the glass and the adhesive that ...
Although this unmistakable scent is recreated through air fresheners and fragrances, the real smell has a dark side that’ll ...
The negotiations are the last round of bargaining between the Big Three carmakers — Stellantis, Ford and GM — and Unifor, ...
The 1990s gave us some of the strangest cars ever made. From the Suzuki X-90 and Isuzu VehiCROSS to the Fiat Multipla and ...
With costs rising and time in short supply, it’s no surprise drivers are prioritising long-lasting quality, but narrowing ...
Aptera solar EV has been independently verified by TUV Rheinland to generate 4.23 to 4.75 kWh of usable solar energy per day ...
The domestic market is really important for the future of our auto industry, and the market has performed terribly for a long ...
"Politicians should back legislation to prevent prompted generative AI outputs from being copyrighted across film, TV and ...
U.S. automakers are keeping quiet about impacts they face if the U.S.-Canada trade war is not resolved. But Honda has spoken ...